Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Ferrand

Showing results (61-70 of 102) with videos related to

Pageof 11
Sort By:
Transplantation|January 2, 2007
Isolation of regulatory T cells in the skin of a human hand-allograft, up to six years posttransplantationAssia Eljaafari, Lionel Badet, Jean Kanitakis, et al.
Science Signaling|September 16, 2020
Engineered IL-10 variants elicit potent immunomodulatory effects at low ligand dosesClaire Gorby, Junel Sotolongo Bellón, Stephan Wilmes, et al.
Transplantation|February 8, 2013
Influence of fractalkine receptor gene polymorphisms V249I-T280M on cancer occurrence after renal transplantationCécile Courivaud, Jamal Bamoulid, Alexandre Loupy, et al.
Blood|February 7, 2002
Retrovirus-mediated gene transfer in primary T lymphocytes impairs their anti-Epstein-Barr virus potential through both culture-dependent and selection process-dependent mechanismsDelphine Sauce, Marie Bodinier, Marina Garin, et al.
International Journal of Cancer|December 3, 2014
CD20 alternative splicing isoform generates immunogenic CD4 helper T epitopesCharline Vauchy, Clementine Gamonet, Christophe Ferrand, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 30, 2021
Kidney Transplant T Cell-Mediated Rejection Occurring After Anti-CD19 CAR T-Cell Therapy for Refractory Aggressive Burkitt-like Lymphoma With 11q Aberration: A Case ReportTristan de Nattes, Vincent Camus, Arnaud François, et al.
Oncoimmunology|April 11, 2018
SALL4 oncogene is an immunogenic antigen presented in various HLA-DR contextsMarie Kroemer, Laurie Spehner, Patricia Mercier-Letondal, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 22, 2014
In vivo proof of concept of adoptive immunotherapy for hepatocellular carcinoma using allogeneic suicide gene-modified killer cellsCéline Leboeuf, Laurent Mailly, Tao Wu, et al.
The Journal of Investigative Dermatology|May 7, 2010
Influence of cyclooxygenase-2 (COX-2) gene promoter polymorphism at position -765 on skin cancer after renal transplantationFrançois Aubin, Cécile Courivaud, Jamal Bamoulid, et al.
Plos One|July 13, 2011
Neuropilin-2 expression promotes TGF-β1-mediated epithelial to mesenchymal transition in colorectal cancer cellsCamille Grandclement, Jean René Pallandre, Séverine Valmary Degano, et al.
Pageof 11

Showing results (61-70 of 102) with videos related to

Sort By:
Pageof 11
Transplantation|January 2, 2007
Isolation of regulatory T cells in the skin of a human hand-allograft, up to six years posttransplantationAssia Eljaafari, Lionel Badet, Jean Kanitakis, et al.
Science Signaling|September 16, 2020
Engineered IL-10 variants elicit potent immunomodulatory effects at low ligand dosesClaire Gorby, Junel Sotolongo Bellón, Stephan Wilmes, et al.
Transplantation|February 8, 2013
Influence of fractalkine receptor gene polymorphisms V249I-T280M on cancer occurrence after renal transplantationCécile Courivaud, Jamal Bamoulid, Alexandre Loupy, et al.
Blood|February 7, 2002
Retrovirus-mediated gene transfer in primary T lymphocytes impairs their anti-Epstein-Barr virus potential through both culture-dependent and selection process-dependent mechanismsDelphine Sauce, Marie Bodinier, Marina Garin, et al.
International Journal of Cancer|December 3, 2014
CD20 alternative splicing isoform generates immunogenic CD4 helper T epitopesCharline Vauchy, Clementine Gamonet, Christophe Ferrand, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 30, 2021
Kidney Transplant T Cell-Mediated Rejection Occurring After Anti-CD19 CAR T-Cell Therapy for Refractory Aggressive Burkitt-like Lymphoma With 11q Aberration: A Case ReportTristan de Nattes, Vincent Camus, Arnaud François, et al.
Oncoimmunology|April 11, 2018
SALL4 oncogene is an immunogenic antigen presented in various HLA-DR contextsMarie Kroemer, Laurie Spehner, Patricia Mercier-Letondal, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 22, 2014
In vivo proof of concept of adoptive immunotherapy for hepatocellular carcinoma using allogeneic suicide gene-modified killer cellsCéline Leboeuf, Laurent Mailly, Tao Wu, et al.
The Journal of Investigative Dermatology|May 7, 2010
Influence of cyclooxygenase-2 (COX-2) gene promoter polymorphism at position -765 on skin cancer after renal transplantationFrançois Aubin, Cécile Courivaud, Jamal Bamoulid, et al.
Plos One|July 13, 2011
Neuropilin-2 expression promotes TGF-β1-mediated epithelial to mesenchymal transition in colorectal cancer cellsCamille Grandclement, Jean René Pallandre, Séverine Valmary Degano, et al.
Pageof 11